Two new large-scale genomic studies have honed in on the main genetic pathway associated with multiple sclerosis (MS), while also uncovering new genetic variations in the disease and suggesting a possible link between MS and other autoimmune diseases.
Eric Small, who leads the Prostate Cancer Program, has been appointed director of investigational therapeutics in the UCSF Comprehensive Cancer Center.